HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eiichi Sato Selected Research

Vaccines

11/2022Prognostic significance of NY-ESO-1 antigen and PIGR expression in esophageal tumors of CHP-NY-ESO-1-vaccinated patients as adjuvant therapy.
11/2018NY-ESO-1 antigen expression and immune response are associated with poor prognosis in MAGE-A4-vaccinated patients with esophageal or head/neck squamous cell carcinoma.
5/2017NY-ESO-1 Protein Cancer Vaccine With Poly-ICLC and OK-432: Rapid and Strong Induction of NY-ESO-1-specific Immune Responses by Poly-ICLC.
10/2014High expression of MAGE-A4 and MHC class I antigens in tumor cells and induction of MAGE-A4 immune responses are prognostic markers of CHP-MAGE-A4 cancer vaccine.
2/2014Vaccination with NY-ESO-1 overlapping peptides mixed with Picibanil OK-432 and montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen.
10/2013Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients.
12/2011A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen.
11/2008Analysis of peripheral and local anti-tumor immune response in esophageal cancer patients after NY-ESO-1 protein vaccination.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eiichi Sato Research Topics

Disease

54Neoplasms (Cancer)
11/2022 - 01/2002
14Proteinuria
01/2021 - 11/2009
13Chronic Renal Insufficiency
01/2020 - 11/2009
9Testicular Neoplasms (Testicular Cancer)
11/2018 - 12/2005
7Esophageal Neoplasms (Esophageal Cancer)
11/2021 - 01/2006
7Diabetic Nephropathies (Diabetic Nephropathy)
01/2021 - 01/2010
6Melanoma (Melanoma, Malignant)
11/2021 - 03/2005
6Dyslipidemias (Dyslipidemia)
01/2021 - 12/2009
6Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 02/2005
6Breast Neoplasms (Breast Cancer)
01/2019 - 05/2013
6Nephrotic Syndrome (Syndrome, Nephrotic)
07/2017 - 01/2014
5Stomach Neoplasms (Stomach Cancer)
01/2020 - 03/2004
5Type 2 Diabetes Mellitus (MODY)
07/2017 - 11/2002
5Diabetic Retinopathy (Retinopathy, Diabetic)
03/2015 - 11/2002
4Disease Progression
01/2020 - 06/2009
4Ductal Carcinoma
12/2017 - 01/2002
3Infections
02/2021 - 05/2002
3Triple Negative Breast Neoplasms
07/2020 - 01/2019
3Atherosclerosis
01/2020 - 02/2005
3Adenocarcinoma of Lung
01/2020 - 01/2017
3IGA Glomerulonephritis (IGA Nephropathy)
01/2020 - 01/2016
3Body Weight (Weight, Body)
07/2017 - 04/2015
3Injection Site Reaction
05/2017 - 12/2011
3Fever (Fevers)
05/2017 - 12/2011
3Chronic Kidney Failure (Chronic Renal Failure)
01/2016 - 02/2011
3Inflammation (Inflammations)
01/2016 - 09/2006
3Anemia
04/2013 - 09/2009
3Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2013 - 07/2009
3Lymphoma (Lymphomas)
03/2012 - 11/2002
3Septic Shock (Toxic Shock Syndrome)
12/2011 - 12/2009
3Carcinoma (Carcinomatosis)
05/2010 - 06/2002
3Rheumatoid Arthritis
10/2003 - 08/2002
2Esophageal Squamous Cell Carcinoma
11/2022 - 04/2020
2Lung Neoplasms (Lung Cancer)
11/2021 - 10/2014
2Colorectal Neoplasms (Colorectal Cancer)
02/2021 - 01/2016
2Anorexia
04/2020 - 01/2016
2Hypertension (High Blood Pressure)
04/2020 - 01/2012
2Hepatocellular Carcinoma (Hepatoma)
06/2019 - 12/2004
2Oral Lichen Planus
01/2018 - 07/2003

Drug/Important Bio-Agent (IBA)

19AntigensIBA
11/2022 - 12/2005
18Proteins (Proteins, Gene)FDA Link
11/2022 - 01/2005
12Retinaldehyde (Retinal)IBA
11/2012 - 09/2002
9Biomarkers (Surrogate Marker)IBA
11/2022 - 01/2011
9Monoclonal AntibodiesIBA
04/2020 - 11/2002
8VaccinesIBA
11/2022 - 11/2008
8Fatty Acid-Binding ProteinsIBA
11/2019 - 12/2009
6Cancer VaccinesIBA
04/2020 - 04/2007
6CreatinineIBA
06/2018 - 11/2009
68-Hydroxy-2'-DeoxyguanosineIBA
01/2012 - 12/2009
5Indicators and Reagents (Reagents)IBA
11/2021 - 03/2005
5LDL CholesterolIBA
01/2021 - 01/2010
5Pharmaceutical PreparationsIBA
04/2020 - 03/2003
5Immune Checkpoint InhibitorsIBA
01/2020 - 01/2017
5LipidsIBA
01/2020 - 11/2009
5CholesterolIBA
06/2018 - 04/2007
5Advanced Glycation End ProductsIBA
05/2012 - 11/2009
5Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2009 - 09/2002
4pullulanIBA
11/2022 - 04/2007
4Neoplasm Antigens (Tumor Antigens)IBA
11/2021 - 11/2008
4Peptides (Polypeptides)IBA
04/2020 - 12/2011
4DNA (Deoxyribonucleic Acid)IBA
01/2020 - 05/2002
4Interleukin-6 (Interleukin 6)IBA
10/2019 - 12/2009
4PicibanilIBA
05/2017 - 11/2009
4CytokinesIBA
01/2016 - 10/2008
4Messenger RNA (mRNA)IBA
05/2013 - 01/2005
4HMGB1 Protein (HMG1)IBA
01/2012 - 12/2009
4N,N-dimethylarginine (asymmetric dimethylarginine)IBA
01/2010 - 11/2009
4Biological ProductsIBA
10/2009 - 01/2002
3oxidized low density lipoproteinIBA
01/2021 - 11/2014
3Glucose (Dextrose)FDA LinkGeneric
01/2021 - 06/2011
3LDL Lipoproteins (beta Lipoproteins)IBA
01/2021 - 03/2012
3EpitopesIBA
04/2020 - 04/2007
3Ezetimibe (Zetia)FDA Link
06/2018 - 12/2009
3TolvaptanFDA Link
01/2017 - 01/2014
3Transcription Factors (Transcription Factor)IBA
01/2016 - 12/2012
3Receptor for Advanced Glycation End ProductsIBA
12/2011 - 11/2009
3EndotoxinsIBA
12/2011 - 12/2009
3Polymyxin B (Aerosporin)FDA LinkGeneric
12/2011 - 07/2009
3LigandsIBA
12/2009 - 07/2003
3Oxygen (Dioxygen)IBA
10/2008 - 09/2002
3NG-Nitroarginine Methyl Ester (L-NAME)IBA
10/2008 - 09/2002
3Chemokine CCL5IBA
01/2005 - 07/2003
3ChemokinesIBA
01/2005 - 07/2003
2Immunoglobulin A (IgA)IBA
11/2022 - 01/2016
2Surface Antigens (Surface Antigen)IBA
01/2022 - 01/2016
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2022 - 01/2012
2Combined VaccinesIBA
11/2021 - 11/2009
2poly ICLCIBA
11/2021 - 05/2017
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2018 - 01/2010
2Atorvastatin (Lipitor)FDA Link
06/2018 - 09/2010
2Phenobarbital (Luminal)FDA Link
12/2017 - 05/2013
2Hormones (Hormone)IBA
12/2017 - 05/2017
2AST 120IBA
10/2016 - 02/2011

Therapy/Procedure

18Therapeutics
11/2022 - 01/2006
9Immunotherapy
01/2020 - 01/2006
7Lasers (Laser)
05/2011 - 11/2002
4Blood Component Removal (Apheresis)
01/2021 - 11/2014
4Drug Therapy (Chemotherapy)
04/2020 - 09/2006
3Neoadjuvant Therapy
01/2020 - 05/2013
3Hemoperfusion
12/2011 - 07/2009